BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20670602)

  • 1. Marginal zone B-cell lymphomas.
    Sagaert X; Tousseyn T
    Discov Med; 2010 Jul; 10(50):79-86. PubMed ID: 20670602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marginal-zone lymphoma.
    Ferreri AJ; Zucca E
    Crit Rev Oncol Hematol; 2007 Sep; 63(3):245-56. PubMed ID: 17583528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-MALT marginal zone lymphoma.
    Thieblemont C; Davi F; Noguera ME; Brière J
    Curr Opin Hematol; 2011 Jul; 18(4):273-9. PubMed ID: 21577105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
    Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
    Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells.
    Novak U; Basso K; Pasqualucci L; Dalla-Favera R; Bhagat G
    Br J Haematol; 2011 Nov; 155(3):362-5. PubMed ID: 21883140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marginal zone lymphomas.
    Zucca E; Bertoni F; Stathis A; Cavalli F
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):883-901, viii. PubMed ID: 18954742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic marginal zone lymphoma: current knowledge and future directions.
    Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
    Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation and management of marginal zone lymphomas.
    Thieblemont C
    Hematology Am Soc Hematol Educ Program; 2005; ():307-13. PubMed ID: 16304396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
    Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
    J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State-of-the-art therapeutics: marginal-zone lymphoma.
    Bertoni F; Zucca E
    J Clin Oncol; 2005 Sep; 23(26):6415-20. PubMed ID: 16155028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALT Lymphomas.
    Cavalli F; Isaacson PG; Gascoyne RD; Zucca E
    Hematology Am Soc Hematol Educ Program; 2001; ():241-58. PubMed ID: 11722987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
    Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
    Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary gastric follicular lymphoma with parafollicular monocytoid B-cells and lymphoepithelial lesions, mimicking extranodal marginal zone lymphoma of MALT.
    Tzankov A; Hittmair A; Müller-Hermelink HK; Rüdiger T; Dirnhofer S
    Virchows Arch; 2002 Dec; 441(6):614-7. PubMed ID: 12461620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal zone lymphoma with a dual cutaneous and leukemic presentation and an aberrant myeloid-monocytic phenotype.
    Keehn CA; Cualing H
    J Cutan Pathol; 2006 Mar; 33(3):236-41. PubMed ID: 16466512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
    Olszewski AJ; Castillo JJ
    Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marginal zone B-cell lymphoma: a retrospective immunophenotypic analysis.
    Kost CB; Holden JT; Mann KP
    Cytometry B Clin Cytom; 2008 Sep; 74(5):282-6. PubMed ID: 18500740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marginal zone B-Cell lymphoma among primary B-Cell lymphoma of Waldeyer's ring: histopathologic and immunohistochemical study of 16 tonsillectomy specimens.
    Kojima M; Nakamura N; Shimizu K; Tamaki Y; Itoh H; Nakamura S
    Int J Surg Pathol; 2008 Apr; 16(2):164-70. PubMed ID: 18417673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the marginal zone lymphomas.
    Vannata B; Stathis A; Zucca E
    Cancer Treat Res; 2015; 165():227-49. PubMed ID: 25655612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.